Decoy Therapeutics is trading at $2.87, up +5.90%, as the move may reflect continued reaction to shareholders approving warrant issuance and reducing authorized shares on September 14, 2026.
- No confirmed company-specific catalyst was identified for the current advance.
- Broader markets are modestly positive, while biotechnology is declining, so sector conditions do not clearly explain the gain.
- Causation remains unconfirmed.